Lexaria Bioscience Corp.
Lexaria Bioscience Corp. (LEXX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LEXX · as of Sep 30, 2025
Ownership Breakdown
25
Institutional Holders
▲ 4 vs Q2
$1.63M
Total Inst. Value
▼ $364,717 vs Q2
20.44M
Shares Outstanding
freeFloat 93.33%
1.72M
13F Shares Held
▼ 580,133 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LEXX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
INVENOMIC CAPITAL MANAGEMENT LP pharmaceutical preparations | 477.2K | 2.61% | 2.61% | $454.63M | Nov 14, 2025 | ▼ 24.3K |
MURCHINSON LTD. pharmaceutical preparations | 419.6K | 2.29% | 2.29% | $399.74M | Nov 14, 2025 | NEW |
VANGUARD GROUP INC pharmaceutical preparations | 258.8K | 1.41% | 1.41% | $246.65M | Nov 7, 2025 | ▲ 125.3K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 174.8K | 95.52% | 95.52% | $166.55M | Nov 12, 2025 | — held |
TORONTO DOMINION BANK pharmaceutical preparations | 140.0K | 76.52% | 76.52% | $133.50M | Nov 14, 2025 | ▲ 6.9K |
STATE STREET CORP pharmaceutical preparations | 39.3K | 21.48% | 21.48% | $37.44M | Nov 14, 2025 | — held |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC pharmaceutical preparations | 35.8K | 19.55% | 19.55% | $29.93M | Oct 29, 2025 | ▲ 5.0K |
BYRNE ASSET MANAGEMENT LLC pharmaceutical preparations | 31.3K | 17.12% | 17.12% | $29.84M | Oct 22, 2025 | ▼ 2.9K |
VIRTU FINANCIAL LLC pharmaceutical preparations | 29.4K | 16.05% | 16.05% | $28.00M | Nov 14, 2025 | NEW |
BLACKROCK, INC. pharmaceutical preparations | 27.4K | 15.00% | 15.00% | $26.15M | Nov 12, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
6
Increased
+139.8K shares7
New Positions
first time holders2
Decreased
−27.2K shares3
Sold Out
fully exitedNet shares change (top 50)
+112.7K
+139.8K / −27.2K
Net new holders
+8
7 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LEXX insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
BUNKA CHRISTOPHER director | Mar 17, 2026 | Gift | 100,000 | — | — | 273.5K | Form 4 ↗ |
BUNKA CHRISTOPHER director | Jul 30, 2025 | Purchase | 11,900 | $0.91 | $10.9K | 281.9K | Form 4 ↗ |
BUNKA CHRISTOPHER director | Jul 29, 2025 | Purchase | 15,600 | $0.92 | $14.4K | 270.0K | Form 4 ↗ |
McKechnie William Edward director | Jul 29, 2025 | Purchase | 5,000 | $0.91 | $4.5K | 18.2K | Form 4 ↗ |
DOCHERTY JOHN MARTIN President & CSO | Jul 29, 2025 | Purchase | 5,376 | $0.93 | $5.0K | 5.4K | Form 4 ↗ |
Carle Vanessa Secretary | Jul 29, 2025 | Purchase | 750 | $0.91 | $682.5 | 750 | Form 4 ↗ |
CHRISTOPHER RICHARD Chief Executive Officer | Jul 29, 2025 | Purchase | 15,000 | $0.91 | $13.6K | 65.0K | Form 4 ↗ |
CHRISTOPHER RICHARD Chief Executive Officer | May 15, 2025 | Award | 150,000 | $1.04 | $156.0K | 350.0K | Form 4 ↗ |
BUNKA CHRISTOPHER director | May 15, 2025 | Award | 11,000 | $1.04 | $11.4K | 184.8K | Form 4 ↗ |
Carle Vanessa Secretary | May 15, 2025 | Award | 15,000 | $1.04 | $15.6K | 75.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Lexaria Bioscience Corp. (LEXX) is primarily owned by institutional investors, who hold approximately 8.4% of total shares outstanding. Company insiders own approximately 6.67%, while retail and public investors account for the remaining 84.93%.
The largest institutional shareholder of Lexaria Bioscience Corp. is INVENOMIC CAPITAL MANAGEMENT LP, holding approximately 477,201 shares — equal to 2.61% of outstanding shares — as of September 30, 2025.
A total of 25 institutional investors currently hold LEXX stock, with a combined institutional value of approximately $1,634,751 as of the most recent 13F filing period.
Frequently asked questions
LEXX ownershipLexaria Bioscience Corp. (LEXX) is primarily owned by institutional investors, who hold approximately 8.4% of shares. The largest shareholder is INVENOMIC CAPITAL MANAGEMENT LP with a 2.61% stake. Company insiders hold 6.67%. Data sourced from SEC Form 13F as of September 30, 2025.